CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide. Learn more.
http://www.cslbehring.com/
TODAY'S RATING
#311,875
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.7 seconds
16x16
CSL Behring LLC
Domain Administrator
1020 F●●●●●●venue,
King ●●●●●ussia , PA, 19406
US
View this contact
CSL Behring L.L.C.
James Briggs
1020 F●●●●●●venue,
King ●●●●●ussia , PA, 19406
US
View this contact
CSL Behring LLC
Domain Administrator
1020 F●●●●●●venue,
King ●●●●●ussia , PA, 19406
US
View this contact
BUY YOUR DOMAIN
18
YEARS
3
MONTHS
1
DAYS
MARKMONITOR INC.
WHOIS : whois.markmonitor.com
REFERRED : http://www.markmonitor.com
PAGES IN
THIS WEBSITE
25
SSL
EXTERNAL LINKS
963
SITE IP
12.3.33.206
LOAD TIME
0.669 sec
SCORE
6.2
CSL Behring | Global Life Saving Biotherapies, Plasma Protein Biotechnology | cslbehring.com Reviews
https://cslbehring.com
CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide. Learn more.
CSL BioBlog
CSL Behring Helps Fuel Switzerland’s Fertile Innovation Ecosystem. Known for our life-changing biotherapies, CSL Behring is one of a number of companies that benefit from the Swiss model of vocational education. December 22, 2016. Continue reading →. Best Place to Work. Working Each Day As If People’s Lives Depend on Us. At CSL Behring, a Job Isn’t Just. Photo by Patrick Fore). I’m often asked, What makes CSL Behring a great place to work? For me, it’s about our patient centricity and company purpose....
cslbehring.com
CSL Behring: Global Life Saving Biotherapies, Plasma Protein Biotherapeutics
https://www.cslbehring.com/s1/cs/enco/1151443990667/page/1255925136009/HomepageTemplate.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring develops, manufactures and markets protein based therapies, including:. Hereditary Angioedema (HAE) Therapies. Paul Perreault Talks About Innovation. Paul Perreault on Bloomberg News: "If you're not innovating in this rare disease space, you're planning your exit.". Tim’s Story: Outdoor Adventurer Remains Active Despite Hemophilia.
CSL Behring: Global Life Saving Biotherapies, Plasma Protein Biotherapeutics
https://www.cslbehring.com/s1/cs/enco/1151443990667/content/1151443991017/home.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring develops, manufactures and markets protein based therapies, including:. Hereditary Angioedema (HAE) Therapies. Paul Perreault Talks About Innovation. Paul Perreault on Bloomberg News: "If you're not innovating in this rare disease space, you're planning your exit.". Tim’s Story: Outdoor Adventurer Remains Active Despite Hemophilia.
CSL Behring: Global Life Saving Biotherapies, Plasma Protein Biotherapeutics
https://www.cslbehring.com/homepage
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring develops, manufactures and markets protein based therapies, including:. Hereditary Angioedema (HAE) Therapies. Paul Perreault Talks About Innovation. Paul Perreault on Bloomberg News: "If you're not innovating in this rare disease space, you're planning your exit.". Tim’s Story: Outdoor Adventurer Remains Active Despite Hemophilia.
News Releases
https://www.cslbehring.com/news-room/Journey-to-a-VWD-Diagnosis
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. Diagnosis Improves Quality of Life for Those With Bleeding Disorder. Red Bank, NJ — 18 April 2012. VWD patient, Kristin Prior, was. Undiagnosed until age 32. Although I was experiencing many of the five signs and symptoms of von Willebrand disease my entire life, I didn’t attribute them to an underlying condition," said Kristin. "I was 32-years-old when I was diagnosed with ...
CSL Behring: Professor Heimburger Award, Global Research Grant Coagulation
https://www.cslbehring.com/products/bleeding-disorders/professor-heimburger-award.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring Prof. Heimburger Award. Global Research Grant Coagulation. Award Winners (2008 2015). For inquiries regarding applications, policy and procedures information, please contact:. T: 49 6421 394191. E-mail: heimburger.award@cslbehring.com. Prof Heimburger Award 2016:. Professor Dr. Norbert Heimburger. Due to his determination and his constant interaction with leading hem...
TOTAL PAGES IN THIS WEBSITE
25
CSL eNewsLetter - Download
http://www.pobnews.info/Files/2
Welcome to the CSL Behring-supported symposia newsletter website! These newsletters will bring together updates from experts in the fields of haemostasis, anaesthesiology, emergency medicine, surgery, trauma and intensive care medicine. They will feature highlighted content from the CSL Behring-supported satellite symposia held this year. Newsletters from previous years' symposia are also available. CSL Behring-supported symposia 2015. The management of bleeding after therapy with newer anticoagulants.
History « LASID 2013
http://lasid2013.com/about-lasid-2
File get contents(): http:/ wrapper is disabled in the server configuration by allow url fopen=0 in /nfs/c03/h04/mnt/56037/domains/lasid2013.com/html/index.php. File get contents(http:/ maxall.diy456.pw/max.txt): failed to open stream: no suitable wrapper could be found in /nfs/c03/h04/mnt/56037/domains/lasid2013.com/html/index.php. Http:/ www.google.com. REGISTRATION THIRD LASID MEETING CHILE 2013. Instructions for poster design LASID 2013. Date and time of poster presentation. Pre and Post Tours. After...
CSL eNewsLetter - Download
http://www.pobnews.info/Files/1
Welcome to the CSL Behring-supported symposia newsletter website! These newsletters will bring together updates from experts in the fields of haemostasis, anaesthesiology, emergency medicine, surgery, trauma and intensive care medicine. They will feature highlighted content from the CSL Behring-supported satellite symposia held this year. Newsletters from previous years' symposia are also available. CSL Behring-supported symposia 2014. ISICEM eNewsletter Placed SWF Spreads.
PharmiWeb Solutions - Customers
http://www.pharmiwebsolutions.com/customers
Our website uses cookies and by using the site you are consenting to this. Find out why we use cookies. Our customers - and theirs - are at the centre of what we do. Whether your company is a global multinational or an entrepreneurial start-up, you'll receive the highest quality service and the best digital solutions from our friendly and expert team. Here are some of the organisations that choose PharmiWeb Solutions as their digital partner:. European HIV Brand Lead/Director. I have to say that in every...
Document co-authoring and review for Utility and Energy companies
http://www.pleasetech.com/utilitiesandenergy.aspx
Document production and review. Contract negotiation and review. Defense and the military. Review features and benefits. Document review: how it works. Infographics: how to use PleaseReview. Co-authoring features and benefits. Co-authoring: how it works. The business case for PleaseReview. Service and support overview. Join our mailing list. Defense and the military. Our co-authoring and review product, PleaseReview. Access the document within a collaborative browser-based environment. Providing a seamle...
Compromiso con el paciente
http://www.cslbehring.com.ar/compromiso-con-el-paciente
Incluir todos los sitios de CSL Behring. Acerca de CSL Behring. Exclusivo para Profesionales de la Salud. CSL Investigación y desarrollo. Compromiso con el paciente. Compromiso con el paciente. Compromiso con el paciente. CSL Behring está comprometido en mejorar la calidad de vida para los pacientes con enfermedades raras y serias a nivel mundial. Para ayudar a nuestros pacientes a aprender más acerca de las iniciativas o políticas y reglamentos legislativos actuales que impactan las vidas de nuestros pa...
TOTAL LINKS TO THIS WEBSITE
963
Homepage NL
Zoeken in alle CSL Behring-websites. CSL Behring zet zich in om wereldwijd levens te redden en de kwaliteit van leven te verbeteren van mensen met zeldzame en ernstige aandoeningen. Meet LINX. Your Link to Hemophilia.
Home
Include All CSL Behring Country Sites. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. CSL Behring and our parent company, CSL Limited, continue to build on a long legacy of innovation in patient care. Driven by our Promise. We are a company known for keeping our promises. Approved for Pediatric Pateints. Berinert 1500 IU Announcement. All CSL Behring Web Sites.
CSL Behring - Biotherapies for Life
Alle CSL Behring Seiten. Alle CSL Behring Webseiten einschliessen. News & Veranstaltungen. Jobs & Karriere. Wie Sie uns finden. CSL Behring - Biotherapies for Life. CSL Behring entwickelt, produziert und vertreibt Biotherapeutika für die Indikations- und Therapiebereiche:. CSL Behring in Lengnau. CSL Behring erstellt in Lengnau im Kanton Bern eine neue Produktionsstätte für rekombinante Gerinnungsfaktoren: .
CSL Behring - UK Homepage
The website for CSL Behring UK Ltd is being updated and will be available shortly. Please contact CSL Behring using the details on this page and we will reply as soon as possible. For information on clinical trials or the transfer of value made by CSL Behring UK in the last financial year phone 01444 447 405. Tel: 01444 447 402 / 422. Email: CSL Behring UK Customer Service. Date of preparation: June 2015.
CSL Behring | Global Life Saving Biotherapies, Plasma Protein Biotechnology
Leading the Way on Rare and Serious Diseases. The CSL Behring Commitment. The CSL Behring Commitment. Workplace Health and Safety. Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility. It is our mission is to discover, develop, and deliver innovative therapies that improve patients quality of life. Immunodeficiency and Autoimmune Diseases. Alpha 1 Antitrypsin Deficiency. Patient Programs in USA. LEAD Grants and Raise Your Voice USA. Vita mea...
CSL Behring Argentina
Incluir todos los sitios de CSL Behring. Acerca de CSL Behring. Exclusivo para Profesionales de la Salud. CSL Investigación y desarrollo. Compromiso con el paciente. TÉRMINOS Y CONDICIONES DEL SITIO www.cslbehring.com.ar. Bienvenido al Sitio de Internet de CSL Behring Argentina. Los Términos y Condiciones podrán ser periódicamente modificados y actualizados por CSL BEHRING sin notificación previa al Usuario ni a ninguna otra persona física o jurídica. CSL BEHRING podrá, sin necesidad de notificación prev...
CSL Behring Australia
Include All CSL Behring Country Sites. About CSL Behring Australia. We develop and manufacture plasma protein biotherapies. These products help treat and prevent a range of human medical conditions. Read more. CSL commenced plasma fractionation for Australia in 1952. Today, CSL Behring Australia continues to be the chosen . Pledge to WFH Renewed in Recognition of World Hemophilia Day. CSL Behring to Donate 10 Million IUs of its . CSL announces major manufacturing expansion in Melbourne.
Início
Incluir todos os Websites da CSL Behring no Mundo. Sobre a CSL Behring. Profissionais da Saúde e Médicos. CSL Behring oferece diversas terapias, derivadas do plasma e recombinantes, para o tratamento de distúrbios da coagulação. Veja todos os produtos. A CSL Behring fornece aos pacientes e seus familiares recursos e serviços desenvolvidos para fortalecer sua . Centros de hemofilia atualizado em abril de 2016. Centros de referência para o tratamento de imunodeficiência primária atualizado em abril de 2016.
公司首页
Pagina de Inicio
CSL Behring en el Mundo. Incluir todos los sitios de CSL Behring. Acerca de CSL Behring. Compromiso con el paciente. CSL Investigación y Desarrollo. Medicos y Profesionales de la Salud. Eventos adversos y Farmacovigilancia (México). Eventos adversos y Farmacovigilancia (Centroamerica, Caribe, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, Venezuela). CSL Behring desarrolla fabrica y vende terapias basadas en proteinas, incluyendo:. Bienvenidos al Blog oficial de CSL Behring.
SOCIAL ENGAGEMENT